* Brain tumors are the leading cause of cancer death in children  
  under 20, now surpassing acute lymphoblastic leukemia. They
  are the deadliest type of childhood cancer.

* The incidence of brain tumors is increasing, but the reasons for
  the increase are unknown.

* Medulloblastoma accounts for about 20% of all brain tumors
  making it the most common type of brain tumor.

* Each year in the United States about 2,000 children under the
  age of 16 are diagnosed with a brain tumor.

* Every day, nine more children are diagnosed with a brain tumor.

* More than 21,000 American children are living with the   
  diagnosis of a primary brain tumor.

* 76% of children diagnosed with a brain tumor are younger than
  15.

* Four out of 10 children with a brain tumor will die of their
  disease within five years of diagnosis.

* There are more than 120 different types of brain tumors, making
  effective treatment very complicated.

* Because brain tumors are located at the control center for
  thought, emotion and movement, their effect on a child's
  physical and cognitive abilities can be devastating.

* Pediatric brain tumors are different from those in adults and are
  often treated differently. Although as many as 60 percent of  
  children will survive, they are often left with long-term side
  effects.

* Benign tumors may recur and may result in death.

* Brain tumors are usually treated by surgery, radiation therapy
  and chemotherapy, either individually or in combination.

* Some brain tumor survivors require physical, cognitive and
  rehabilitation services to allow them to return to tasks of
  everyday life.

* Enhancing the quality of life of children with brain tumors
  requires access to quality specialty care and ready availability   
  of follow-up care and rehabilitative services.

* Improving the outlook for children with brain tumors requires
  research into the causes of the disease and better treatments
  for it.

Facts from Pediactric Brain Tumor Foundation

 

home | contact us | donate | privacy policy | disclaimer